Latest PMD News From Around the Web

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […]

Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced a Vaping Panel to detect the use of Marijuana, CBD and Nicotine. This test provides a way for schools and businesses to detect the ingestion of these drugs by all methods including electronic cigarettes or smoking. Hair testing provides several significant advantages over other methods of testing including a 90-day lookback period for the ingestion of drugs.

Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the first FDA-cleared hair test for cotinine, the predominant metabolite for nicotine. This test provides a way for schools and businesses to detect the ingestion of nicotine by all methods including smoking or the use of electronic cigarettes. Hair testing provides several significant advantages over other methods of testing including a 90-day lookback period for the ingestion of drugs.

Psychemedics Corporation (PMD) will hold its Annual Meeting of Stockholders (“Annual Meeting”) on Thursday, May 14, 2020 at 2:00 p.m. ET. Psychemedics Corporation has decided to hold the Annual Meeting in a virtual meeting format for this year, in light of public health concerns regarding the COVID-19 outbreak. As described in the proxy materials for the Annual Meeting, shareholders who held their shares as of the close of business on March 17, 2020, the record date, are entitled to vote in the Annual Meeting.